Saturday, March 2, 2024

CATEGORY

Pricing and Reimbursement

Key Update on the Pricing of Pharmaceutical Products and Its Impacts in Turkiye

A recent regulation amendment has significantly changed the Decree on the Pricing of Pharmaceutical Products. This change concerns the fixed exchange rate of the...

Introducing Confidential Reimbursement Prices to Shield from International Benchmarks in Germany

Germany is poised for another significant overhaul of its drug pricing and reimbursement legislation, introducing a framework that incorporates "confidential reimbursement prices." This move...

Medicare Prescription Payment Plan: A New Era of Financial Relief for Part D Enrollees

The Centers for Medicare & Medicaid Services (CMS) has recently issued further guidance on the Medicare Prescription Payment Plan, a key component of the...

Revised Guidelines for Kidney Dialysis Treatment Reimbursement in Belgium

The reimbursement system for dialysis treatment in Belgium operates under a specific agreement, known as the Convention, established between the National Institute for Health...

Medicare and Medicaid Services Enter a New Era: Initiating Price Negotiations with Pharma Companies

The Centers for Medicare and Medicaid Services (CMS) has begun Medicare price negotiations for the first ten drugs as required by the Inflation Reduction...

Released of 2024 Norwegian Reimbursement Tariffs and Pathology Activity Codes (APAT)

In 2024, significant updates were made to the reimbursement scheme for outpatient pathology services in Norway. This scheme, introduced gradually since 2022, utilizes the...

Netherlands Updates Restricted Reimbursement List for Medical Procedures

The Dutch Healthcare Institute (ZIN) recently released an updated list outlining medical procedures eligible for reimbursement under basic health insurance, accompanied by specific restrictions...

ZIN’s Rulings: MR-linac Radiotherapy Denied Insurance Reimbursement, HIFU Treatment Greenlit

In December 2023, the Dutch Healthcare Institute (ZIN) made significant announcements regarding the coverage and reimbursement of certain medical treatments. These updates are particularly...

Global Disparities in Insulin Pricing: Impact on Healthcare Worldwide

A vial of insulin, which costs an estimated $2 to $4 to produce, reveals stark disparities in insulin pricing across the globe. In the...

Poland’s DNUR Amendment: Transforming Healthcare Reimbursement and Pricing Landscape

A substantial amendment on reimbursement and pricing to Poland's Reimbursement Act, known as DNUR (Duża Nowelizacja Ustawy Refundacyjnej), officially took effect on November 1,...

Latest news

Sticky Image